These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 34165025)
1. Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis. Zhao F; Liu A; Gong X; Chen H; Wei J; Chen B; Chen S; Yang R; Fan Y; Mao R Tumori; 2022 Feb; 108(1):63-76. PubMed ID: 34165025 [TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma. Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365 [TBL] [Abstract][Full Text] [Related]
3. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC. Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188 [TBL] [Abstract][Full Text] [Related]
4. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress. Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863 [TBL] [Abstract][Full Text] [Related]
5. RECQL4 Inhibits Radiation-Induced Tumor Immune Awakening via Suppressing the cGAS-STING Pathway in Hepatocellular Carcinoma. Hong W; Zhang Y; Wang S; Li Z; Zheng D; Hsu S; Zhou J; Fan J; Chen Z; Xia X; Zeng Z; Gao Q; Yu M; Du S Adv Sci (Weinh); 2024 Apr; 11(16):e2308009. PubMed ID: 38381090 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced NIPP1 activation enhances metastatic potential and predicts poor prognosis in hepatocellular carcinoma. Huang Y; Tao Y; Hu K; Lin F; Li X; Feng T; Wang ZM Tumour Biol; 2016 Nov; 37(11):14903-14914. PubMed ID: 27644248 [TBL] [Abstract][Full Text] [Related]
7. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation. Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380 [TBL] [Abstract][Full Text] [Related]
8. Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia. Niu Y; Lin Z; Wan A; Sun L; Yan S; Liang H; Zhan S; Chen D; Bu X; Liu P; Chen C; He W; Lu X; Wan G Hepatology; 2021 Sep; 74(3):1461-1479. PubMed ID: 33813748 [TBL] [Abstract][Full Text] [Related]
9. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Li Q; Ni Y; Zhang L; Jiang R; Xu J; Yang H; Hu Y; Qiu J; Pu L; Tang J; Wang X Signal Transduct Target Ther; 2021 Feb; 6(1):76. PubMed ID: 33619246 [TBL] [Abstract][Full Text] [Related]
10. KHDRBS1 as a novel prognostic signaling biomarker influencing hepatocellular carcinoma cell proliferation, migration, immune microenvironment, and drug sensitivity. Fan R; Liu F; Gong Q; Liu D; Tang S; Shen D Front Immunol; 2024; 15():1393801. PubMed ID: 38660302 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer. Yang KS; Xu CQ; Lv J Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma. Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238 [TBL] [Abstract][Full Text] [Related]
13. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis. Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150 [No Abstract] [Full Text] [Related]
14. Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma. Li X; Pan YF; Chen YB; Wan QQ; Lin YK; Shang TY; Xu MY; Jiang TY; Pei MM; Tan YX; Dong LW; Wan XY Cell Death Dis; 2024 Apr; 15(4):300. PubMed ID: 38684648 [TBL] [Abstract][Full Text] [Related]
15. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
16. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma. Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition. Ibrahim AA; Schmithals C; Kowarz E; Köberle V; Kakoschky B; Pleli T; Kollmar O; Nitsch S; Waidmann O; Finkelmeier F; Zeuzem S; Korf HW; Schmid T; Weigert A; Kronenberger B; Marschalek R; Piiper A Clin Cancer Res; 2017 Jul; 23(14):3896-3905. PubMed ID: 28167508 [No Abstract] [Full Text] [Related]
18. Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma. Jiang Z; Zhou Q; Ge C; Yang J; Li H; Chen T; Xie H; Cui Y; Shao M; Li J; Tian H Cancer Lett; 2019 Apr; 447():1-11. PubMed ID: 30673593 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820 [TBL] [Abstract][Full Text] [Related]
20. Abnormal Expression of Centromere Protein U Is Associated with Hepatocellular Cancer Progression. Yu Y; Chen X; Zhang W; Liu J Biomed Res Int; 2021; 2021():4051192. PubMed ID: 34957303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]